Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-020774

Director sold 1,799 shares at $23.31 ($41,935)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vakiener Victoria Director 2024-05-02 Sale 10b5-1 −1,799 $23.31 $41,935 30,205 D
Open-market sales · 1,799 sh · avg $23.31 · $41,935
Loading xslF345X05/wk-form4_1715033068.xml…